hormone Tagged Articles
Chicago woman sues Bayer over Yaz-related injuries
A Chicago woman who claims she was injured as a result of taking Yaz filed a lawsuit on November 4 against Bayer in the United States District Court for the Northern District of Illinois. According to the lawsuit, the plaintiff
Off-label marketing boosts drug company profits
Off-label marketing is an illegal yet commonly employed sales strategy that some big pharmaceutical companies practice to broaden the appeal of a drug and boost sales. One of the most blatant examples of off-label marketing involved Bayer Healthcare’s blockbuster birth
Comedian lampoons the absurdity of drug ads
Writer-comedian Sarah Haskins has produced another segment of her popular satire on Current TV’s Target: Women, this time calling out the absurdity of television advertising in marketing drugs to women.
Injured by Yaz, SC nurse files lawsuit against Bayer
A 33-year-old nurse from South Carolina has filed suit against Bayer Healthcare Pharmaceuticals, charging that Yaz caused her multiple personal injuries. According to a report published by Reuters, the woman received a Yaz prescription from her dermatologist in March 2008
Switzerland investigates the death of young Yaz user
A Swiss health agency is investigating the death of a young woman in Switzerland who died while taking Bayer AG’s birth control pill Yaz. Bloomberg reported that Swissmedic (Switzerland’s drug therapy regulatory agency) and an investigative judge are probing the
Yaz health risks: better safe than sorry?
Bayer Healthcare’s blockbuster drug Yaz has come under fire in recent years for its potential to cause a spectrum of health problems. Bayer has downplayed these serious risks while drawing attention to some of the drug’s other uses as treatments
Prempro increases risk of dying from small cell lung cancer
Women who took Wyeth’s hormone replacement therapy (HRT) Prempro at least five years are at greater risk of dying from non-small cell lung cancer, according to a recent study presented at an American Society of Clinical Oncology meeting.
Tamoxifen with antidepressants may raise risk of breast cancer recurrence
The Food and Drug Administration (FDA) is expected to issue a warming to doctors about an increased risk of the recurrence of breast cancer with patients taking both the breast cancer drug tamoxifen and select antidepressants, according to a study
HRT-breast cancer risk same regardless of family history
Women on hormone replacement therapy (HRT) who have no family history of breast cancer have the same risk of developing breast cancer as women with a family history who are on HRT, according to a University of Rochester Medical Center
More studies help women make educated decisions about HRT
The more than 2 million baby-boomer women who are approaching menopause may find themselves in a precarious position when it comes to handling hot flashes and mood swings. Should they risk the threat of breast cancer from use of hormone
